Attachment L-1.2 Non-Disclosure Agreement.docx

DOCX document 23 KB Posted

Attached to
DRAFT RFP TRICARE Pharmacy Services, 5th Generation (TPharm5)
Solicitation number
HT940220R0002
Issued by

About this file

This draft request for proposals concerns pharmacy services for the Defense Health Agency's TRICARE Pharmacy Program, referred to as TPharm5. The anticipated contract would have an 18-month base period for transition, followed by seven 1-year option periods for healthcare delivery and a potential 6-month extension. Services required include retail pharmacy network administration, mail order pharmacy services, specialty pharmacy services, and care coordination for eligible TRICARE beneficiaries. The Defense Health Agency seeks industry feedback on requirements and contract structure by January 17, 2020, and may issue a formal solicitation in mid-2020.

View the file

Other files

File Type Posted
DSADHA_SSVTemplate_20170101.pdf PDF
QA CAS Applicability Specific Clauses (May 15 2020).pdf PDF
Responses to Industry on Revised Draft Section C 20200504.pdf PDF
TPharm5 - Overview of Changes to Draft Section C.DOCX DOCX document
TPharm5 Section C Draft RFP2 2020-4-6.docx DOCX document
DHA Responses to Industry on Draft RFP 20200318.pdf PDF
TPharm5 Draft RFP Info Session 20191211.pdf PDF
Data Pkg 2 - Retail Utilization by Drug.xlsx XLSX spreadsheet
Attachment L-9.8 PA_ST_QL List.XLSX XLSX spreadsheet
Data Pkg 15 IHS_Pharmacy_Claims_Volume_2017_&_2018.xlsx XLSX spreadsheet
Data Pkg 3 TRICARE Retail Pharmacy Claim Volume.xlsx XLSX spreadsheet
Attachment L-9.4 Covered OTC List - MHS GENESIS.xlsx XLSX spreadsheet
Attachment L-10 Small Business Participation Plan.docx DOCX document
TPharm5 Draft Section J 20191127.docx DOCX document
Data Pkg 8 Mail and Retail Monthly Utilizers.xlsx XLSX spreadsheet
Attachment J-1 Definitions.DOCX DOCX document
TPharm5 Draft Section M 20191202.docx DOCX document
Attachment L-9.6 Self-Admin Injectables List.xlsx XLSX spreadsheet
Attachment L-19 Past Performance Questionnaire Template Tab F 20191120.docx DOCX document
Attachment L-3 Specialty Reimbursement for Use in Determining Incentiv....docx DOCX document
Attachment L-9 Benefit Design Document_TPharm5.xlsx XLSX spreadsheet
Data Pkg 14 Retail Claims with COB.xlsx XLSX spreadsheet
Attachment L-9.5 Non-Formulary List.xlsx XLSX spreadsheet
Data Pkg 5 MOP Utilization by Drug.xlsx XLSX spreadsheet
Data Pkg 25 - OHI Development.xlsx XLSX spreadsheet
Data Pkg 22 - Paid Claims and Rejects - Retail.xlsx XLSX spreadsheet
TPharm5 Draft Section C 20191202.docx DOCX document
Attachment L-5 Guaranty_Agreement.pdf PDF
Data Pkg 6 - MOP Utilization.xlsx XLSX spreadsheet
Attachment L-13 VA_Pharmacy_Listing_2019.xlsx XLSX spreadsheet
Data Pkg 19 Historical_TMDS_Volume_2017-2018.xlsx XLSX spreadsheet
Attachment L-1.1 List of Data Packages.docx DOCX document
Data Pkg 13 - MTF Claims Volumes by Site.xlsx XLSX spreadsheet
TPharm5 Draft Section I 20191120.docx DOCX document
Attachment L-19.1 PPI Tool Instructions.docx DOCX document
Attachment L-9.3 Covered OTCs - Purchased Care.xlsx XLSX spreadsheet
Attachment J-5 TPharm5 Award Fee Plan 20191122.docx DOCX document
TPharm5 Draft Section D 20191120.docx DOCX document
Attachment L-12 IHS_Pharmacy_Listing_2019.xlsx XLSX spreadsheet
TPharm5 Draft Section E 20191120.docx DOCX document
Attachment L-18 CDRL Supplemental Bid Schedule.xlsx XLSX spreadsheet
Data Pkg 7 Specialty Drug Utilization, Retail and Mail.xlsx XLSX spreadsheet
Data Pkg 16 VA_VA CHDR Volume.xlsx XLSX spreadsheet
TPharm5 Draft Section H 20191121.docx DOCX document
Attachment L-7 Teaming Subcontractor Consent Ltr.docx DOCX document
Attachment L-2 Retail Network Reimbursement Table.docx DOCX document
Attachment L-4 Negotiated Specialty Retail Replenished Dispensing Fees.docx DOCX document
Tpharm5 Draft Section G 20191202.docx DOCX document
Data Pkg 10 - Compound Utilizers.xlsx XLSX spreadsheet
TPharm5 Draft Section F 20191202.docx DOCX document
Show 40 more

Latest 50 of 73 listed here. See the rest on GovTribe.

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Attachment L-1.2 Non-Disclosure Agreement

The parties to this Non-Disclosure Agreement are the Defense Health Agency ("DHA") and (Name of Entity), an entity that is a potential offeror to the Department of Defense (DOD) for TRICARE Pharmacy Program (TPharm5).

In order to protect certain confidential and protected information ("Confidential and Protected Information") which will be disclosed by reason of 's (Name of Entity) participation as a potential offeror in the above described solicitation, the undersigned ("Recipient"), acting for and in behalf of the entity named above, agrees as follows:

1. Definition of Confidential and Protected Information. The "Confidential and Protected Information" disclosed under this Agreement is described as:

All iterations of Detail Level Claims Data for TPharm.

2. Use of Protected Confidential and Protected Information.

(Entity Name) shall use the Confidential and Protected Information only for the purposes of participating as a potential offeror in the above described solicitation only. The Confidential and Protected Information will not be used for any other purposes including commercial purposes or government purposes.

(Entity Name) shall maintain the confidentiality of any and all materials, information, or actions as they relate to issues involving the above described solicitation that may be discussed with TRICARE personnel and other TRICARE contractors.

3. Protection of Confidential and Protected Information.

(Entity Name) shall protect the Confidential and Protected Information by not divulging, publishing, or revealing by word, conduct, or any other means, any Confidential and Protected Information to any other person, except in accordance with direction from the DHA Contracting Officer responsible for the above described solicitation.

(Entity Name) agrees not to decode/unscramble any data received from the Government pursuant to its participation in the above described solicitation.

(Entity Name) understands that it must use the same degree of care, but no less than a reasonable degree of care, to prevent the unauthorized use, dissemination or publication of the Confidential and Protected Information to any third party, or to any employee who does not have a need to know such information, except to the Government in response to and in support of 's (Entity Name) participation in the above described solicitation.

(Entity Name) agrees to be responsible for compliance with this agreement by each of its employees, subcontractors, venders, partners, etc.

(Entity Name) agrees to promptly report any mishandling, loss or unauthorized disclosure of Confidential and Protected Information.

(Entity Name) also understands that an employee's failure to comply with the requirements to protect Confidential and Protected Information may result in penalties that may be imposed by (EntityName) as an employer for violation of employment rules and/or penalties that may be imposed for a violation of law.

4. Destruction and/or Return of Data. When the data is no longer necessary for purposes of participating in the above described solicitation, or at the direction of the DHA Contracting Officer, (Entity Name) agrees to contact the DHA Contracting Officer for instruction regarding the destruction and/or return of the data.

5. Entire Agreement. This Agreement sets forth the entire agreement with respect to the Confidential and Protected Information disclosed herein and supersedes all prior or contemporaneous agreements concerning such Confidential and Protected Information, whether written or oral. All additions or modifications to this Agreement must be made in writing.

6. Governing Law. This Agreement is made under and shall be construed according to the laws of the United States.

Name:

Title:

Address:

Email Address :

Business Phone Number:

HT940220R0002 Page 1 of 2 Attachment L-1.2

File details come from the government source that posted it. Updated .